PRECIGEN, INC. Land
PRECIGEN, INC. (PGEN) had Land of $5.67 million as of 2014-09-30, per its 10-Q filed 2014-11-13.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Land and Land Improvements
us-gaap:Land · last filed 2014-11-13
- 2014-09-30: Land $5.67M.
- 2014-06-30: Land $55.00K.
- 2014-03-31: Land $55.00K.
- 2013-12-31: Land $55.00K.
| Period end | Land |
|---|---|
| 2014-09-30 | $5.67M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $55.00K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $55.00K 10-Q · filed 2014-05-09 |
| 2013-12-31 | $55.00K 10-Q · filed 2014-11-13 |
| 2013-09-30 | $55.00K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $55.00K 10-Q/A · filed 2013-10-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |